- Q1 2024 ReShape Lifesciences Inc Earnings Call TranscriptMay 15, 2024Earnings
- Q4 2023 ReShape Lifesciences Inc Earnings Call TranscriptApr 01, 2024Earnings
- Q3 2023 ReShape Lifesciences Inc Earnings Call TranscriptNov 08, 2023€0.615Earnings
- Q2 2023 ReShape Lifesciences Inc Earnings Call TranscriptAug 07, 2023€1.22 (-1.61%)Earnings
- ReShape Lifesciences Inc at OTC Markets Life Science Investor Forum TranscriptJun 22, 2023
- Q1 2023 ReShape Lifesciences Inc Earnings Call TranscriptMay 15, 2023€2.06 (-0.96%)Earnings
- Q4 2022 ReShape Lifesciences Inc Earnings Call TranscriptApr 25, 2023€2.26 (-3.42%)Earnings
- Q3 2022 ReShape Lifesciences Inc Earnings Call TranscriptNov 14, 2022€10.24 (-2.24%)Earnings
- Q2 2022 ReShape Lifesciences Inc Earnings Call TranscriptAug 15, 2022€23.93 (+7.87%)Earnings
- Q1 2022 ReShape Lifesciences Inc Earnings Call TranscriptMay 23, 2022€37.14 (-1.93%)Earnings
- Q4 2021 ReShape Lifesciences Inc Earnings Call TranscriptMar 28, 2022€62 (+3.77%)Earnings
- ReShape Lifesciences Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) TranscriptSep 20, 2021
- Q4 2019 Obalon Therapeutics Inc Earnings Call TranscriptFeb 27, 2020Earnings
- Q3 2019 Obalon Therapeutics Inc Earnings Call TranscriptNov 08, 2019Earnings
- Q2 2019 Obalon Therapeutics Inc Earnings Call TranscriptJul 24, 2019Earnings
- Q4 2018 Obalon Therapeutics Inc Earnings Call TranscriptFeb 22, 2019Earnings
Q3 2022 ReShape Lifesciences Inc Earnings Call Transcript
Good morning, and thank you for joining the ReShape Lifesciences Second Quarter 2022 Conference Call. I would now like to turn the call over to Paula Schwartz from Rx Communications. Please go ahead.
Good morning, and thank you for joining the ReShape Lifesciences Third Quarter 2022 Earnings Call. I'm pleased to be joined by Paul Hickey, President and Chief Executive Officer of ReShape Life Sciences; and Thomas Stankovich, Chief Financial Officer. Paul will provide an overview and update on the company's activities, and Tom will review the final results for the quarter. He will then turn the call back over to Paul for some closing remarks, after which we will open up the call to a question-and-answer session.
As a reminder, this conference call as well as ReShape Lifesciences' SEC filings and website including the Investor Information section of the website, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)